Cysticercosis is an important tropical parasitic worm infestation. This infection can result in cyst in any organs of human beings including to brain. The brain involvement of cysticercosis or neurocyticercosis is an important neurological infection that can cause serious neuruological problem. A good sanitation is the basic prevention for cysticercosis. Nevertheless, the hope is the use of vaccination. Here, the author briefly reviews and discusses on the present situation of neurocysticercosis vaccine.
INTRODUCTION
Neurological infection is usually an important problem in neurology. There are several tropical neurological infections and an important group is the parasitic neurological infection. Several parasites can infect neurological system and cause serious neurological problem. Of several diseases, cysticercosis is a common problem in tropical medicine. 1 In general cysticercosis is an important tropical parasitic worm infestation cause by pathogenic Taenia spp. Cestode. 1 This infection can result in cyst in any organs of human beings including to brain. The brain involvement of cysticercosis or neurocyticercosis is an important neurological infection that can cause serious neuruological problem 2 . Although most cases might be asymptomatic silent infection, some case care presents severe neurological problems as well as death. 2, 3 A good sanitation is the basic prevention for cysticercosis. 4 Nevertheless, the hope is the use of vaccination. Here, the author briefly reviews and discusses on the present situation of neurocysticercosis vaccine.
Researches on neurocysticercosis vaccine: present situation
There are some reports regarding neurocysticercosis vaccine. Most reports are on the basic studies on the antigenic property and epitopes finding that can be useful for further vaccine development. The use of bioinformatics technique becomes a new useful tool for epitope searching for cysticerocis vaccine development. The good example is the report by Zimic et al. 5 Zimic et al. reported the "immunoinformatics prediction of linear epitopes from Taenia solium TSOL18.
5 " An additional study by Guo et al. on "mapping of Taenia solium TSOL18 antigenic epitopes by phage display library" is also very interesting. 6 Guo et al. noted that "the antigenic epitope could be mapped through screening the phage-displayed peptide libraries with mAbs and a mimotope of TSOL18, which could provide an alternative approach for the diagnosis and development of a vaccine for T. solium. 6 " The data from these reports are used for further study on epitope testing and there are also some reports on testing in animal models. Nevertheless, as already noted, most of the studies are on the animal models and there is still no report on trial on human subjects. The recent trial on human mononuclear cell by Díaz-Orea et al. is very interesting. 9 Díaz-Orea et al. reported that "S3Pvac vaccine antigens" could be a useful adjuvant for treatment of the patients with neurocysticercosis. 9 Hence, the new vaccine candidate can be a hope for further development of therapeutic vaccine against neurocysticercosis.
CONCLUSION
There are ongoing researches on the new vaccines against cysticercosis and this is an actual hope for prevention and control of cysticercosis including to neurocysticercosis. Nevertheless, as a tropical neglected disease, the limitation of grant and fund for cysticerosis vaccine research and development can be expected and this might result in delayed success in new vaccine finding.
